Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals

被引:33
作者
Stuckey, Ashley [1 ]
Febbraro, Terri [1 ]
Laprise, Jessica [1 ]
Wilbur, Jennifer S. [1 ]
Lopes, Vrishali [1 ]
Robison, Katina [1 ]
机构
[1] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2016年 / 39卷 / 04期
关键词
genetic referral; breast cancer; BRCA mutation; BRCA2 MUTATION CARRIERS; RISK-ASSESSMENT; DIAGNOSIS; CONSULTATION; PHYSICIANS; KNOWLEDGE; IMPACT;
D O I
10.1097/COC.0000000000000073
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Genetic predisposition is responsible for 5% to 10% of breast cancer. The National Comprehensive Cancer Network (NCCN) established guidelines delineating appropriate candidates for genetic counseling. This study aims to determine referral patterns for genetic counseling in women who met such guidelines. Materials and Methods: Utilizing an institutional tumor registry, patients from an academic oncology program who met a subset of NCCN guidelines for genetic referrals between 2004 and 2010 were identified (breast cancer diagnosis <= 50 y without a known BRCA mutation). A retrospective chart review was conducted. Statistics were analyzed using SAS version 9.2. Results: A total of 314 patients were identified and 107 (34.1%) were referred for genetic counseling. Median age at diagnosis was younger for those referred versus not referred (43 and 46 y; P < 0.0001). Women were more likely referred with a family history suspicious for an inherited cancer syndrome (67.3% vs. 36.2%; P < 0.0001). There was no difference in stage at diagnosis, insurance, or race among women referred. Those patients who choose prophylactic contralateral mastectomy were likely to have been referred for genetic counseling (63.6% vs. 36.4%, P < 0.0001). Among patients referred, 77.6% consulted with a genetics counselor, 95.2% underwent genetic testing, and 16.5% had a BRCA mutation. Conclusions: Genetic counseling and testing is being underutilized in women who meet NCCN referral guidelines. Age and family history were noted to be predictive of referral for genetic evaluation. Further research is needed to determine additional factors that may impact not only referral rates but subsequent care for women with possible genetic predispositions to cancer.
引用
收藏
页码:363 / 367
页数:5
相关论文
共 50 条
  • [21] Professionals' knowledge, attitude and referral behaviour of preimplantation genetic diagnosis for hereditary breast and ovarian cancer
    Gietel-Habets, J. J. G.
    de Die-Smulders, C. E. M.
    Tjan-Heijnen, V. C. G.
    Derks-Smeets, I. A. P.
    van Golde, R.
    Gomez-Garcia, E.
    van Osch, L. A. D. M.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2018, 36 (02) : 137 - 144
  • [22] Perceived risk and adherence to breast cancer screening guidelines among women with a familial history of breast cancer: A review of the literature
    Walker, Meghan J.
    Chiarelli, Anna M.
    Knight, Julia A.
    Mirea, Lucia
    Glendon, Gord
    Ritvo, Paul
    BREAST, 2013, 22 (04) : 395 - 404
  • [23] Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines Who Is at Risk?
    Blakely, Andrew M.
    Comissiong, Danielle S.
    Vezeridis, Michael P.
    Miner, Thomas J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 754 - 759
  • [24] National Comprehensive Cancer Network guidelines compliance of a sarcoma service: A retrospective review
    Blank, Alan T.
    Larson, Brandon Michael
    Shaw, Sara
    Wakefield, Connor J.
    King, Tricia
    Jones, Kevin B.
    Randall, R. Lor
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2020, 11 (06): : 389 - 396
  • [25] Survivorship care plans and adherence to breast and cervical cancer screening guidelines among cancer survivors in a national sample
    Santos-Teles, Marco
    Modugu, Ganesh
    Silva, Isabel C.
    Bandera, Elisa V.
    George, Mridula
    Qin, Bo
    Smith, Jonathan
    Stephenson, Ruth
    Mattes, Malcolm D.
    Eskander, Mariam F.
    SUPPORTIVE CARE IN CANCER, 2024, 32 (12)
  • [26] Trends in adherence to NCCN guidelines for breast conserving therapy in women with Stage I and II breast cancer: Analysis of the 1998-2008 National Cancer Data Base
    Patrick, Jilma L.
    Hasse, Michelle E.
    Feinglass, Joe
    Khan, Seema A.
    SURGICAL ONCOLOGY-OXFORD, 2017, 26 (04): : 359 - 367
  • [28] Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations
    Foluso O. Ademuyiwa
    Patricia Salyer
    Yinjiao Ma
    Sherri Fisher
    Graham Colditz
    Katherine Weilbaecher
    Laura J. Bierut
    Breast Cancer Research and Treatment, 2019, 178 : 151 - 159
  • [29] Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations
    Ademuyiwa, Foluso O.
    Salyer, Patricia
    Ma, Yinjiao
    Fisher, Sherri
    Colditz, Graham
    Weilbaecher, Katherine
    Bierut, Laura J.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (01) : 151 - 159
  • [30] Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging
    Omar Abdel-Rahman
    Breast Cancer Research and Treatment, 2018, 172 : 231 - 238